FDA - PDS Symposium IX: Agenda
Event Agenda
Wednesday, October 7, 2020 | 12:00 - 3:00 PM (EDT)
12:00 - 12:10 PM (EDT) |
Welcome
|
12:10 - 12:40 PM |
Keynote: Rare cancer registries – Impact on clinical practice, drug development and regulators
|
12:40 - 1:25 PM |
Panel 1: How do rare cancer registries impact clinical decision making? Moderator: Dave Reese, MD, Executive Vice President of Research & Development; Amgen, Inc.
Questions and Answers |
1:30 - 2:15 PM |
Panel 2: How do rare cancer registries advance drugs in development? Moderator: Zhen Su, MD, MBA, Senior Vice President, Head of US & Global Oncology Franchise; EMD Serono, a business of Merck KGaA, Darmstadt Germany
Questions and Answers |
2:15 - 2:40 PM |
Fireside Chat: Generating clinical evidence for biomarker-driven indications Sean Khozin, MD, MPH, Vice President, Global Head of Data Strategy; Janssen Research & Development, LLC, to interview Josh Bilenker, MD, Chief Executive Officer; Loxo Oncology, Inc. |
2:40 - 2:50 PM |
Call to Action & Next Steps
|